Your browser doesn't support javascript.
loading
(+)-[18F]Flubatine as a novel α4ß2 nicotinic acetylcholine receptor PET ligand-results of the first-in-human brain imaging application in patients with ß-amyloid PET-confirmed Alzheimer's disease and healthy controls.
Tiepolt, Solveig; Becker, Georg-Alexander; Wilke, Stephan; Cecchin, Diego; Rullmann, Michael; Meyer, Philipp M; Barthel, Henryk; Hesse, Swen; Patt, Marianne; Luthardt, Julia; Wagenknecht, Gudrun; Sattler, Bernhard; Deuther-Conrad, Winnie; Ludwig, Friedrich-Alexander; Fischer, Steffen; Gertz, Hermann-Josef; Smits, René; Hoepping, Alexander; Steinbach, Jörg; Brust, Peter; Sabri, Osama.
Afiliación
  • Tiepolt S; Department of Nuclear Medicine, University of Leipzig, Liebigstraße 18, 04103, Leipzig, Germany. Solveig.tiepolt@medizin.uni-leipzig.de.
  • Becker GA; Department of Nuclear Medicine, University of Leipzig, Liebigstraße 18, 04103, Leipzig, Germany.
  • Wilke S; Department of Nuclear Medicine, University of Leipzig, Liebigstraße 18, 04103, Leipzig, Germany.
  • Cecchin D; Department of Medicine, University-Hospital of Padova, Via Giustiniani 2, 35128, Padova, Italy.
  • Rullmann M; Department of Nuclear Medicine, University of Leipzig, Liebigstraße 18, 04103, Leipzig, Germany.
  • Meyer PM; Department of Nuclear Medicine, University of Leipzig, Liebigstraße 18, 04103, Leipzig, Germany.
  • Barthel H; Department of Nuclear Medicine, University of Leipzig, Liebigstraße 18, 04103, Leipzig, Germany.
  • Hesse S; Department of Nuclear Medicine, University of Leipzig, Liebigstraße 18, 04103, Leipzig, Germany.
  • Patt M; Department of Nuclear Medicine, University of Leipzig, Liebigstraße 18, 04103, Leipzig, Germany.
  • Luthardt J; Department of Nuclear Medicine, University of Leipzig, Liebigstraße 18, 04103, Leipzig, Germany.
  • Wagenknecht G; Electronic Systems (ZEA-2), Central Institute for Engineering, Electronics and Analytics, Research Centre Juelich, Wilhelm-Johnen-Straße, 52428, Juelich, Germany.
  • Sattler B; Department of Nuclear Medicine, University of Leipzig, Liebigstraße 18, 04103, Leipzig, Germany.
  • Deuther-Conrad W; Helmholtz-Zentrum Dresden-Rossendorf, Research Site Leipzig, Permoserstraße 15, 04318, Leipzig, Germany.
  • Ludwig FA; Helmholtz-Zentrum Dresden-Rossendorf, Research Site Leipzig, Permoserstraße 15, 04318, Leipzig, Germany.
  • Fischer S; Helmholtz-Zentrum Dresden-Rossendorf, Research Site Leipzig, Permoserstraße 15, 04318, Leipzig, Germany.
  • Gertz HJ; Department of Psychiatry, University of Leipzig, Semmelweisstraße 10, 04103, Leipzig, Germany.
  • Smits R; ABX advanced biochemical compounds GmbH, Heinrich-Gläser-Straße 10, 01454, Radeberg, Germany.
  • Hoepping A; ABX advanced biochemical compounds GmbH, Heinrich-Gläser-Straße 10, 01454, Radeberg, Germany.
  • Steinbach J; Helmholtz-Zentrum Dresden-Rossendorf, Bautzener Landstr. 400, 01328, Dresden, Germany.
  • Brust P; Helmholtz-Zentrum Dresden-Rossendorf, Research Site Leipzig, Permoserstraße 15, 04318, Leipzig, Germany.
  • Sabri O; Department of Nuclear Medicine, University of Leipzig, Liebigstraße 18, 04103, Leipzig, Germany.
Eur J Nucl Med Mol Imaging ; 48(3): 731-746, 2021 03.
Article en En | MEDLINE | ID: mdl-32935187

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedad de Alzheimer Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Alemania